✦ LIBER ✦

Beyond interferon and ribavirin: Antiviral therapies for hepatitis C virus

✍ Scribed by Ann D. Kwong; Sarah Cowherd; Peter Mueller

Book ID: 119226038
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 507 KB
Volume: 3
Category: Article
ISSN: 1740-6773
DOI: 10.1016/j.ddstr.2006.06.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-ribavirin combination therapy

Interferon-ribavirin combination therapy for chronic hepatitis C

✍ Solko W. Schalm; J. T. Brouwer; L. Chemello; A. Alberti; A. Bellobuono; G. Ideo; 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 466 KB

Pegylated interferon and ribavirin thera

Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection

✍ F. Legrand-Abravanel; F. Nicot; A. Boulestin; K. Sandres-Sauné; J.P. Vinel; L. A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract Hepatitis C Virus (HCV) is classified into six genotypes. Genotype 4 is now spreading in Europe, especially among drug users, who are often infected with both HCV and the human immunodeficiency virus (HIV). Previous studies have shown that HCV‐4 responds poorly to interferon. Pegylated

Development of novel antiviral therapies

Development of novel antiviral therapies for hepatitis C virus

✍ Kai Lin 📂 Article 📅 2010 🏛 SP Wuhan Institute of Virology, CAS 🌐 English ⚖ 526 KB

Depression and antiviral response to int

Depression and antiviral response to interferon-based therapy for hepatitis C virus infection

✍ Jennifer M. Loftis; Benjamin J. Morasco; Peter Hauser 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 1 views

We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6

Therapy of hepatitis C: Alpha interferon

Therapy of hepatitis C: Alpha interferon and ribavirin

✍ O Reichard; R Schvarcz; O Weiland 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

Ribavirin is a nucleoside analogue that has been evaluated as a therapy of chronic hepatitis C alone and in combination with alpha interferon. Ribavirin is well absorbed orally and is typically given in doses of 1,000 to 1,200 mg/d. Three randomized, placebo-controlled studies comprising more than 1

Hepatitis B and C Virus Resistance to An

Hepatitis B and C Virus Resistance to Antiviral Therapies

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 658 KB